V
Veracyte, Inc.
VCYT · NASDAQ · Healthcare · 3.3B
Price · close
$42.31
+1.24% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
50.1×
Price / net assetsP/B
2.5×
Enterprise value / EBITDAEV/EBITDA
33.5×
Free cash flow yieldFCF yield
3.8%
Return on equityROE
5.1%
Operating margin
14.3%
Net debt / EBITDAbalance-sheet strength
-3.6×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.